Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Dihydrolipoic Acid and Free Radical Damage: Scientific Evidence

Dihydrolipoic acid (DHLA) is the reduced form of alpha-lipoic acid, a compound that has garnered significant scientific attention for its antioxidant properties. DHLA is a potent antioxidant, capable of scavenging a variety of reactive oxygen species (free radicals) and regenerating other antioxidants such as vitamin C and glutathione. Its unique chemical structure allows it to function in both aqueous and lipid environments, making it versatile in cellular antioxidant defense.

Preclinical studies (in vitro and animal models) have consistently shown that DHLA can neutralize free radicals and protect against oxidative damage. These studies indicate that DHLA can reduce oxidative stress markers, inhibit lipid peroxidation, and improve cellular redox status. Some mechanistic studies also highlight DHLA’s ability to chelate metal ions, thereby limiting free radical generation via the Fenton reaction.

However, while the scientific rationale for DHLA’s use in mitigating free radical damage is strong, direct human clinical trials using DHLA specifically (as opposed to alpha-lipoic acid itself) are limited. Most clinical studies have focused on alpha-lipoic acid supplementation, which is partly converted to DHLA in the body. These studies suggest benefit in conditions characterized by oxidative stress, such as diabetic neuropathy, but the evidence is not robust enough to warrant a higher rating due to the lack of large-scale, DHLA-specific trials.

In summary, the use of DHLA to support or treat free radical damage is supported by a solid biochemical rationale and preclinical evidence, but direct clinical evidence is still emerging.

More about Dihydrolipoic Acid
More about Free Radical Damage

Other ingredients used for Free Radical Damage

Other health conditions supported by Dihydrolipoic Acid

Products containing Dihydrolipoic Acid